Srs Capital Advisors, Inc. Ampio Pharmaceuticals, Inc. Transaction History

Srs Capital Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$0.08 - $21.0 $42,456 - $11.1 Million	-530,700 Reduced 84.35%	98,472 $6,000
Q2 2021 Aug 02, 2021	BUY	$1.56 - $1.98 $21,080 - $26,755	13,513 Added 2.19%	629,172 $1.05 Million
Q2 2020 Aug 06, 2020	SELL	$0.47 - $0.72 $541,675 - $829,800	-1,152,500 Reduced 65.18%	615,659 $392,000
Q1 2020 May 13, 2020	BUY	$0.36 - $0.74 $636,537 - $1.31 Million	1,768,159 New	1,768,159 $734,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.